HOT NEWS
COAGADEX® Earns Orphan Drug Designation for Rare Bleeding Disorder
Kedrion Biopharma has announced a major step forward in rare disease treatment: its plasma-derived therapy, COAGADEX® (Coagulation Factor X, Human), has received Orphan Drug...
EMA Issues Positive Opinion on Mirdametinib for NF1-Associated Plexiform Neurofibromas
On 22 May 2025, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended granting a conditional marketing authorisation for mirdametinib...
Kedrion Biopharma Advances COAGADEX for Rare Bleeding Disorder with New FDA Designation and Clinical Trial
Kedrion Biopharma has received Orphan Drug Designation from the U.S. FDA for COAGADEX®, a plasma-derived human coagulation factor concentrate, targeting Acquired Factor X...
Long-Term Benefits of TIBSOVO® in IDH1-Mutated AML: A Summary of the Phase 3 AGILE Trial Results
Servier recently published updated long-term data from the Phase 3 AGILE trial in Blood Advances, confirming the sustained survival benefit of TIBSOVO® (ivosidenib) combined with...
European Commission Approves DARZALEX Faspro for High-Risk Smouldering Multiple Myeloma
On July 23, 2025, the European Commission approved DARZALEX Faspro® (daratumumab), co-formulated with Halozyme's ENHANZE® technology, as monotherapy for adult patients with...
Don't hesitate to contact us ,please click inquiry.
We will be to keep your information strictly confidential
Leave Your Message
TOP 6 USER FOLLOW
TOP
1
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements.
TOP
2
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in Parkinson's disease.
TOP
3
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and older.
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular edema, and macular edema secondary to retinal vein occlusion.
DatopotamabDeruxtecan-dlnk(Datroway)
Treatment of unresectable or metastatic HR-positive, HER2-negative breast cancer in adults who have received prior endocrine therapy and chemotherapy.
Vadadustat(Vafseo)
Treatment of anemia in adults with chronic kidney disease (CKD) who have been on dialysis for at least three months.
Company Introduction
Seagull Pharmacy offers a diverse range of medications, including both prescription
and over-the-counter drugs.
The platform prioritizes medication quality and provides 24/7 services.
Whether it's consultation on medication purchases or post-sale support, Seagull Pharmacy strives to deliver
meticulous care in every detail,
consistently placing customers' needs at the forefront.
Click here to contact us
LATEST ARTICLES
- How to relieve the side effects of Gilteritinib (Xospata)?Side effect management of Lazertinib requires targeted measures based on specific reaction types, with key focus on the prevention and control of venous thromboembolism, skin reactions, and ocular toxicity.
501
2026-02-13 11:29:38 - What are the side effects of Gilteritinib (Xospata)?Gilteritinib (Xospata) is a FLT3 inhibitor. Its adverse reactions mainly involve the hematological system, cardiovascular system, digestive system, etc. Different management measures should be taken according to the severity.501
2026-02-13 11:01:40
- Where to Buy Venetoclax TabletsVenetoclax is a targeted medication used for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and acute myeloid leukemia (AML). As a prescription drug, its purchase and use must be strictly under medical supervision.501
2026-02-12 13:49:24
- Indications of Venetoclax TabletsVenetoclax is an innovative BCL‑2 inhibitor that plays an important role in the treatment of hematologic malignancies.500
2026-02-12 13:46:30
- Side Effects of Mavacamten (Camzyos)Mavacamten (Camzyos) is a cardiac myosin inhibitor indicated for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM), New York Heart Association (NYHA) functional class II–III, to improve functional capacity and symptoms. However, its use is associated with a range of potential risks, side effects, and strict medication management requirements that require close attention.501
2026-02-12 13:16:41
- What are the precautions for mavacamten (Camzyos)?Mavacamten (Camzyos) is a novel cardiac myosin inhibitor indicated for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM) of New York Heart Association (NYHA) functional Class Ⅱ–Ⅲ. It provides a new therapeutic option for these patients by improving their functional capacity and symptoms.503
2026-02-11 10:33:05
- Mechanism of Action of Valsartan Tablets (Diovan)Valsartan Tablets (Diovan) is a widely used angiotensin II receptor antagonist (ARB) in clinical practice, indicated mainly for the treatment of hypertension, heart failure, and reduction of cardiovascular risk post-myocardial infarction.500
2026-02-10 13:00:51
- Important Dosage and Administration InformationAs an angiotensin II receptor antagonist, valsartan is widely used in the treatment of hypertension, heart failure, and post-myocardial infarction. Appropriate selection of dosage form, dose adjustment, and preparation method are critical to ensuring efficacy and medication safety.501
2026-02-10 11:23:07
- Overview of Common Side Effects of VibramycinAs a broad-spectrum antibiotic, doxycycline (Vibramycin) demonstrates significant efficacy in treating a variety of infections, yet certain side effects may occur during its administration.501
2026-02-09 11:06:11
- Indications of EntrectinibEntrectinib (Rozlytrek) is a targeted anticancer drug indicated for cancer patients with specific gene mutations.502
2026-02-09 10:26:45
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved